Intraluminal Flow Diverter Design Primer for Neurointerventionalists

References

1. 1.↵
   2. Brinjikji W,
   3. Murad MH,
   4. Lanzino G, et al

   . Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis. Stroke 2013;44:442–47 doi:10.1161/STROKEAHA.112.678151 pmid:23321438

   Abstract/FREE Full Text
2. 2.↵
   2. Dandapat S,
   3. Mendez-Ruiz A,
   4. Martínez-Galdámez M, et al

   . Review of current intracranial aneurysm flow diversion technology and clinical use. J Neurointerv Surg 2021;13:54–62 doi:10.1136/neurintsurg-2020-015877 pmid:32978269

   Abstract/FREE Full Text
3. 3.↵
   2. Ravindran K,
   3. Casabella AM,
   4. Cebral J, et al

   . Mechanism of action and biology of flow diverters in the treatment of intracranial aneurysms. Neurosurgery 2020;86:S13–19 doi:10.1093/neuros/nyz324 pmid:31838528

   CrossRefPubMed
4. 4.↵
   2. Rouchaud A,
   3. Ramana C,
   4. Brinjikji W, et al

   . Wall apposition is a key factor for aneurysm occlusion after flow diversion: a histologic evaluation in 41 rabbits. AJNR Am J Neuroradiol 2016;37:2087–91 doi:10.3174/ajnr.A4848 pmid:27390319

   Abstract/FREE Full Text
5. 5.↵
   2. Aquarius R,
   3. de Korte A,
   4. Smits D, et al

   . The importance of wall apposition in flow diverters. Neurosurgery 2019;84:804–10 doi:10.1093/neuros/nyy092 pmid:29659995

   CrossRefPubMed
6. 6.↵
   2. Ma J,
   3. You Z,
   4. Byrne J, et al

   . Design and mechanical properties of a novel cerebral flow diverter stent. Ann Biomed Eng 2014;42:960–70 doi:10.1007/s10439-013-0967-3 pmid:24449051

   CrossRefPubMed
7. 7.↵
   2. Dabir D,
   3. Feisst A,
   4. Thomas D, et al

   . Physical properties of venous stents: an experimental comparison. Cardiovasc Intervent Radiol 2018;41:942–50 doi:10.1007/s00270-018-1916-1 pmid:29492633

   CrossRefPubMed
8. 8.↵
   2. Kühn AL,
   3. Wakhloo AK,
   4. Gounis MJ, et al

   . Use of self-expanding stents for better intracranial flow diverter wall apposition. Interv Neuroradiol 2017;23:129–36 doi:10.1177/1591019916681981 pmid:27956518

   CrossRefPubMed
9. 9.↵
   2. Kühn AL,
   3. Rodrigues KM,
   4. Wakhloo AK, et al

   . Endovascular techniques for achievement of better flow diverter wall apposition. Interv Neuroradiol 2019;25:344–47 doi:10.1177/1591019918815294 pmid:30486725

   CrossRefPubMed
10. 10.↵
    2. Ni XY,
    3. Pan CW,
    4. Gangadhara Prusty B

    . Numerical investigations of the mechanical properties of a braided non-vascular stent design using finite element method. Comput Methods Biomech Biomed Engin 2015;18:1117–25 doi:10.1080/10255842.2013.873420 pmid:24867297

    CrossRefPubMed
11. 11.↵
    2. Suzuki T,
    3. Takao H,
    4. Fujimura S, et al

    . Relationships between geometrical parameters and mechanical properties for a helical braided flow diverter stent. Technol Health Care 2017;25:611–23 doi:10.3233/THC-160535 pmid:28506004

    Abstract/FREE Full Text
12. 12.↵
    2. Kastrati A,
    3. Mehilli J,
    4. Dirschinger J, et al

    . Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation 2001;103:2816–21 doi:10.1161/01.cir.103.23.2816 pmid:11401938

    Abstract/FREE Full Text
13. 13.↵
    2. Kim JH,
    3. Kang TJ,
    4. Yu WR

    . Mechanical modeling of self-expandable stent fabricated using braiding technology. J Biomech 2008;41:3202–12 doi:10.1016/j.jbiomech.2008.08.005 pmid:18804764

    CrossRefPubMed
14. 14.↵
    2. Starke RM,
    3. Thompson J,
    4. Pagani A, et al

    . Preclinical safety and efficacy evaluation of the Pipeline Vantage Embolization Device with Shield Technology. J Neurointerv Surg 2020;12:981–86 doi:10.1136/neurintsurg-2020-016043 pmid:32487767

    Abstract/FREE Full Text
15. 15.↵
    2. Kallmes DF,
    3. Ding Y,
    4. Dai D, et al

    . A second-generation, endoluminal, flow-disrupting device for treatment of saccular aneurysms. AJNR Am J Neuroradiol 2009;30:1153–58 doi:10.3174/ajnr.A1530 pmid:19369609

    Abstract/FREE Full Text
16. 16.↵
    2. Rogers C,
    3. Edelman ER

    . Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 1995;91:2995–3001 doi:10.1161/01.cir.91.12.2995 pmid:7796511

    Abstract/FREE Full Text
17. 17.↵
    2. Hong B,
    3. Wang K,
    4. Huang Q, et al

    . Effects of metal coverage rate of flow diversion device on neointimal growth at side branch ostium and stented artery: an animal experiment in rabbit abdominal aorta. Neuroradiology 2012;54:849–55 doi:10.1007/s00234-011-0984-6 pmid:22170078

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Sadasivan C,
    3. Cesar L,
    4. Seong J, et al

    . An original flow diversion device for the treatment of intracranial aneurysms: evaluation in the rabbit elastase-induced model. Stroke 2009;40:952–58 doi:10.1161/STROKEAHA.108.533760 pmid:19150864

    Abstract/FREE Full Text
19. 19.↵
    2. Mut F,
    3. Cebral J

    . Effects of flow-diverting device oversizing on hemodynamics alteration in cerebral aneurysms. AJNR Am J Neuroradiol 2012;33:2010–16 doi:10.3174/ajnr.A3080 pmid:22555581

    Abstract/FREE Full Text
20. 20.↵
    2. Tong X,
    3. Han M,
    4. Wu Z, et al

    . Effects of different stent size selection on Pipeline embolization device treatment of intracranial aneurysms. Ther Adv Neurol Disord 2023;16:17562864231151475 doi:10.1177/17562864231151475 pmid:36776531

    CrossRefPubMed
21. 21.↵
    2. Shapiro M,
    3. Raz E,
    4. Becske T, et al

    . Variable porosity of the Pipeline embolization device in straight and curved vessels: a guide for optimal deployment strategy. AJNR Am J Neuroradiol 2014;35:727–33 doi:10.3174/ajnr.A3742 pmid:24072622

    Abstract/FREE Full Text
22. 22.↵
    2. Ding Y,
    3. Tieu T,
    4. Kallmes D

    . Experimental testing of a new generation of flow diverters in sidewall aneurysms in rabbits. AJNR Am J Neuroradiol 2015;36:732–36 doi:10.3174/ajnr.A4167 pmid:25414000

    Abstract/FREE Full Text
23. 23.↵
    2. Girdhar G,
    3. Andersen A,
    4. Pangerl E, et al

    . Thrombogenicity assessment of Pipeline Flex, Pipeline Shield, and FRED flow diverters in an in vitro human blood physiological flow loop model. J Biomedical Materials Res 2018;106:3195–202 doi:10.1002/jbm.a.36514

    CrossRef
24. 24.↵
    2. Tan LA,
    3. Keigher KM,
    4. Munich SA, et al

    . Thromboembolic complications with Pipeline Embolization Device placement: impact of procedure time, number of stents and pre-procedure P2Y12 reaction unit (PRU) value. J Neurointerv Surg 2015;7:217–21 doi:10.1136/neurintsurg-2014-011111 pmid:24553344

    Abstract/FREE Full Text
25. 25.↵
    2. Lieber BB,
    3. Sadasivan C

    . Endoluminal scaffolds for vascular reconstruction and exclusion of aneurysms from the cerebral circulation. Stroke 2010;41:S21–25 doi:10.1161/STROKEAHA.110.595066 pmid:20876497

    Abstract/FREE Full Text
26. 26.↵
    2. Dholakia R,
    3. Sadasivan C,
    4. Fiorella DJ, et al

    . Hemodynamics of flow diverters. J Biomech Eng 2017;139 doi:10.1115/1.4034932 pmid:27727400

    CrossRefPubMed
27. 27.↵
    2. Oliver AA,
    3. Carlson KD,
    4. Bilgin C, et al

    . Bioresorbable flow diverters for the treatment of intracranial aneurysms: review of current literature and future directions. J Neurointerv Surg 2023;15:178–82 doi:10.1136/neurintsurg-2022-018941 pmid:35636949

    Abstract/FREE Full Text
28. 28.↵
    2. Chiu AH,
    3. Phillips TJ

    . Future directions of flow diverter therapy. Neurosurgery 2020;86:S106–16 doi:10.1093/neuros/nyz343 pmid:31838531

    CrossRefPubMed
29. 29.↵
    2. Matsuda Y,
    3. Jang DK,
    4. Chung J, et al

    . Preliminary outcomes of single antiplatelet therapy for surface-modified flow diverters in an animal model: analysis of neointimal development and thrombus formation using OCT. J Neurointerv Surg 2019;11:74–77 doi:10.1136/neurintsurg-2018-013935 pmid:29804090

    Abstract/FREE Full Text
30. 30.↵
    2. Akgul E,
    3. Onan HB,
    4. Akpinar S, et al

    . The DERIVO embolization device in the treatment of intracranial aneurysms: short-and midterm results. World Neurosurg 2016;95:229–40 doi:10.1016/j.wneu.2016.07.101 pmid:27514698

    CrossRefPubMed
31. 31.↵
    2. Yoshizawa K,
    3. Kobayashi H,
    4. Kaneki A, et al

    . Poly (2-methoxyethyl acrylate) (PMEA) improves the thromboresistance of FRED flow diverters: a thrombogenic evaluation of flow diverters with human blood under flow conditions. J Neurointerv Surg 2023;15:1001–06 doi:10.1136/jnis-2022-019248 pmid:36180206

    Abstract/FREE Full Text
32. 32.↵
    2. Bhogal P,
    3. Bleise C,
    4. Chudyk J, et al

    . The p48_HPC antithrombogenic flow diverter: initial human experience using single antiplatelet therapy. J Int Med Res 2020;48:300060519879580 doi:10.1177/0300060519879580 pmid:31612765

    CrossRefPubMed
33. 33.↵
    2. Xu L,
    3. Zhao B,
    4. Liu X, et al

    . Computational methods applied to analyze the hemodynamic effects of flow-diverter devices in the treatment of cerebral aneurysms: current status and future directions. Med Nov Technol Devices 2019;3:100018 doi:10.1016/j.medntd.2019.100018

    CrossRef
34. 34.↵
    2. Rao J,
    3. Pan Bei H,
    4. Yang Y, et al

    . Nitric oxide-producing cardiovascular stent coatings for prevention of thrombosis and restenosis. Front Bioeng Biotechnol 2020;8:578 doi:10.3389/fbioe.2020.00578 pmid:32671029

    CrossRefPubMed
35. 35.↵
    2. Liu P,
    3. Liu Y,
    4. Li P, et al

    . Rosuvastatin-and heparin-loaded poly (l-lactide-co-caprolactone) nanofiber aneurysm stent promotes endothelialization via vascular endothelial growth factor type A modulation. ACS Appl Mater Interfaces 2018;10:41012–18 doi:10.1021/acsami.8b11714 pmid:30403126

    CrossRefPubMed
36. 36.
    2. Bhogal P,
    3. Moreno RM,
    4. Ganslandt O, et al

    . Use of flow diverters in the treatment of unruptured saccular aneurysms of the anterior cerebral artery. J Neurointerv Surg 2017;9:283–89 doi:10.1136/neurintsurg-2016-012648 pmid:27789789

    Abstract/FREE Full Text